Gebauer Julie Jarecke 4

What Happened
Julie J. Gebauer, President — Health, Wealth & Career at Willis Towers Watson (WTW), was awarded a total of 112.726 restricted share units (RSUs) on 2026-07-15. The filing shows three award lines: 11.669 RSUs (acquired at $0.00), 82.226 RSUs (derivative/dividend-equivalent, $0.00) and 18.831 RSUs (derivative/dividend-equivalent, $0.00). These are awards (not purchases or sales) and carry no immediate cash price; they represent equity compensation that will convert to ordinary WTW shares per plan terms.

Key Details

• Transaction date: 2026-07-15; Filing date: 2026-07-17 (appears timely under Form 4 rules).
• Award amounts: 11.669 RSUs; 82.226 RSUs (derivative); 18.831 RSUs (derivative) — total 112.726 RSUs. Price per unit reported: $0.00.
• Shares owned after transaction: not disclosed in the filing.
• Notable footnotes:
  • Dividend-equivalent rights accrued on previously reported RSUs and vest on same schedule as underlying awards (F1).
  • Certain RSUs settle 1:1 for ordinary shares six months after the reporting person’s termination (F2, F4).
  • Some RSUs reflect contributions/matching under the company’s Non‑Qualified Deferred Savings and Stable Value Excess plans (F3, F5).
• Transaction type: Award/Grant (code A) — not an open-market trade or option exercise.

Context
These entries are equity compensation and derivative/dividend-equivalent rights that will convert to ordinary WTW shares only when plan/vesting conditions are met (including post-termination settlement rules noted in the footnotes). Awards and dividend-equivalent RSUs are routine components of executive pay and do not by themselves indicate an intent to buy or sell stock in the open market.